The activation of ERRα by tumor cells in response to radiation or chemotherapy provides a means to escape apoptosis; thus, ERRα inhibition has been recently proposed in combination with conventional antineoplastic therapy to maximize tumor cell death in esophageal [109] and in breast cancer [110]. The gene discussed is ESRRA; the disease is breast carcinoma.